Zeke Capital Advisors, LLC Virpax Pharmaceuticals, Inc. Transaction History

Zeke Capital Advisors, LLC

  • $1.53 Billion
  • Q4 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$4.14 - $22.9 $186,300 - $1.03 Million
-45,000 Closed
0 $0
Q1 2021

Apr 21, 2021
BUY
$4.39 - $6.53 $197,550 - $293,850
45,000 New
45,000 $212,000

Others Institutions Holding VRPX

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Virpax Pharmaceuticals, Inc.

VRPX Quotes by TradingView
  • Ticker VRPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,714,600
  • Market Cap $7.97M
  • Description
  • Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical no...
More about VRPX
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email